Effects of simvastatin, bezafibrate and gemfibrozil on the quantity and composition of plasma lipoproteins
- 31 December 1990
- journal article
- clinical trial
- Published by Elsevier in Atherosclerosis
- Vol. 85 (2-3) , 211-217
- https://doi.org/10.1016/0021-9150(90)90113-w
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Lipoprotein lipase prevents the hepatic lipase-induced reduction in particle size of high density lipoproteins during incubation of human plasmaAtherosclerosis, 1990
- Pravastatin therapy in primary moderate hypercholesterolaemia: changes in metabolism of apolipoprotein B‐containing lipoproteinsJournal of Internal Medicine, 1990
- Metabolism of human intermediate and very low density lipoprotein subfractions from normal and dysbetalipoproteinemic plasma. In vivo studies in rat.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
- Plasma lipoprotein distribution of apolipoprotein E in familial hypercholesterolemia.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1987
- Change in very low‐, low‐, and high‐density lipoproteins during lipid lowering (bezafibrate) therapy: studies in type IIA and type IIb hyperlipoproteinaemiaEuropean Journal of Clinical Investigation, 1986
- Apolipoprotein A and B (Sf 100-400) metabolism during bezafibrate therapy in hypertriglyceridemic subjects.Journal of Clinical Investigation, 1984
- Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in manPublished by American Medical Association (AMA) ,1984
- Lipoprotein receptors and cholesterol homeostasisBiochimica et Biophysica Acta (BBA) - Reviews on Biomembranes, 1983
- Separation of plasma lipoproteins by density-gradient ultracentrifugationAnalytical Biochemistry, 1975
- PROTEIN MEASUREMENT WITH THE FOLIN PHENOL REAGENTJournal of Biological Chemistry, 1951